DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas-Reference-Cited by-同舟云学术

DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas

Published:2022-03 Issue: Volume:24 Page:218-229
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Zhu Xizhou^ORCID,Perales-Puchalt Alfredo^ORCID,Wojtak Krzysztof^ORCID,Xu Ziyang^ORCID,Yun Kun,Bhojnagarwala Pratik S.^ORCID,Bordoloi Devivasha,Park Daniel H.^ORCID,Liaw Kevin^ORCID,Bah Mamadou A.^ORCID,Lieberman Paul M.,Gary Ebony N.^ORCID,Patel Ami^ORCID,Weiner David B.^ORCID

Funder

W. W. Smith Charitable Trust

INOVIO Pharmaceuticals

NCI

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference49 articles.

1. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis;de Martel;Lancet Glob. Health,2020

2. Epstein-Barr virus: more than 50 years old and still providing surprises;Young;Nat. Rev. Cancer,2016

3. The global landscape of EBV-associated tumors;Shannon-Lowe;Front. Oncol.,2019

4. Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma;Zhang;N. Engl. J. Med.,2019

5. Comprehensive molecular characterization of gastric adenocarcinoma;Nature,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The footprint of gut microbiota in gallbladder cancer: a mechanistic review;Frontiers in Cellular and Infection Microbiology;2024-05-07

2. The viral etiology of EBV-associated gastric cancers contributes to their unique pathology, clinical outcomes, treatment responses and immune landscape;Frontiers in Immunology;2024-03-26

3. Siglec-7 glyco-immune binding mAbs or NK cell engager biologics induce potent antitumor immunity against ovarian cancers;Science Advances;2023-11-03

4. Synergistic potential of immune checkpoint inhibitors and therapeutic cancer vaccines;Seminars in Cancer Biology;2023-01